Delivery Order SPE2DB22D2005-SPE2DB24FJMS1
Award Date
5/20/24
Potential Completion Date
5/21/24
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,771.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product, with a completion date of November 29, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $6,325.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $1,055.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a respiratory medication, with an ultimate completion date of August 23, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,904.95 firm fixed-price contract is for Advair HFA 115-21 MCG Inhaler 12GM, a respiratory medication. The contract has an ultimate completion date of January 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $6,153.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, with a completion date of February 20, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing structure, with no set-aside designation. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of Advair HFA 230-21 mcg inhalers to the U.S. government. The contract, valued at $5,788.21, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical...
This federal contract award, valued at $8,139.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, which is a respiratory medication. This contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of January 10, 2025. The contract is not designated as a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,806.05 Firm Fixed Price Delivery Order contract is for the supply of Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a period of performance through May 22, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,258.23 firm-fixed-price delivery order is for the supply of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, with a completion date of November 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,562.04 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide Advair HFA 115-21 MCG inhalers. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that was previously awarded to Amerisourcebergen Drug Corp by DLA for the provision of a comprehensive range of pharmaceutical...